bloomberg
Why having a risky genetic mutation isn’t necessarily doom and gloom
Most people think carrying a gene variant associated with a disease means automatically getting that disease, according to Sekar Kathiresan, ...
Gene therapy could be revolutionary—if we can figure out how to pay for it
Dozens of revolutionary gene therapies that mend faulty strands of DNA are on their way, bringing the power to eliminate ...
Why it was no surprise that controversial CRISPR babies happened in China
The headline-making births last November of the world’s first gene-edited babies (twin girls) was unsurprising in one way: The scientist ...
23andMe and weight loss: Can consumer DNA-testing company deliver?
Consumer DNA-testing giant 23andMe Inc. plans to add new wellness offerings it hopes will help its customers shed a few pounds, but ...
Asians finally have drugs ‘perfectly tailored’ to their genetics
For decades, much of the pipeline of medical innovation has flowed from West to East. Now a string of companies ...
CRISPR co-creator Jennifer Doudna: Clinical human gene editing 5 to 10 years away
A pioneer of the Crispr gene-editing technology that’s taken Wall Street by storm says the field is probably five to 10 years ...
Gary Hirshberg’s Stonyfield faces hypocrisy backlash over misleading labels
Glass house alert: Stonyfield's yogurts are filled with unknown and unlabeled chemicals. Shouldn't you "just label it", Gary? ...
